Pediatric Methemoglobinemia Follow-up
- Author: Michael J Verive, MD; Chief Editor: Max J Coppes, MD, PhD, MBA more...
Further Inpatient Care
- Acquired methemoglobinemia: The underlying cause should be identified, and measures should be instituted to avoid further exposure of the patient to precipitating causes.
- Hereditary methemoglobinemia: Methemoglobin levels and adverse effects of medication should be monitored on an ongoing basis.
Further Outpatient Care
- Once the treatment has been instituted for acquired methemoglobinemia, identification and removal of the precipitating cause is all that is necessary, with instruction to avoid future exposure to the precipitating agent (and related agents).
- If treatment is indicated on an ongoing basis, as in some cases of congenital methemoglobinemia, patients should be observed for effect and toxicity. Both methylene blue and ascorbic acid have been used for this purpose.
Inpatient & Outpatient Medications
- See Medication and Further Outpatient Care.
Transfer
- The most important step in management is recognition of this entity without subjecting the patient to extensive and invasive studies for cardiopulmonary conditions.
- Once the diagnosis is established, management should be instituted as indicated.
Deterrence/Prevention
- Recognition and avoidance of precipitating factors (such as ingestion of nitrate-contaminated water and exposure to oxidizing medications) are important, especially in susceptible populations.
Patient Education
- Patients with both congenital and acquired methemoglobinemia should receive instruction regarding avoidance of precipitating factors.
- Patients receiving therapy for chronic methemoglobinemia should receive balanced information regarding the risks and benefits expected with treatment.
Jolly BT, Monico EP, McDevitt B. Methemoglobinemia in an infant: case report and review of the literature. Pediatr Emerg Care. Oct 1995;11(5):294-7. [Medline].
Ash-Bernal R, Wise R, Wright SM. Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals. Medicine (Baltimore). Sep 2004;83(5):265-73. [Medline].
Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: Etiology, Pharmacology, and Clinical Management. Annals of Emergency Medicine. 1999;34:646-656. [Medline].
Yano SS, Danish EH, Hsia YE. Transient methemoglobinemia with acidosis in infants. J Pediatr. Mar 1982;100(3):415-8. [Medline].
Lavezzi AM, Mohorovic L, Alfonsi G, Corna MF, Matturri L. Brain iron accumulation in unexplained fetal and infant death victims with smoker mothers--the possible involvement of maternal methemoglobinemia. BMC Pediatr. Jul 6 2011;11:62. [Medline]. [Full Text].
Erkekoglu P, Baydar T. Evaluation of nitrite contamination in baby foods and infant formulas marketed in Turkey. Int J Food Sci Nutr. May 2009;60(3):206-9. [Medline].
[Guideline] Greer FR, Shannon M. Infant methemoglobinemia: the role of dietary nitrate in food and water. Pediatrics. Sep 2005;116(3):784-6. [Medline]. [Full Text].
Fung HT, Lai CH, Wong OF, Lam KK, Kam CW. Two cases of methemoglobinemia following zopiclone ingestion. Clin Toxicol (Phila). Feb 2008;46(2):167-70. [Medline].
Skold A, Klein R. Symptomatic-Low Grade Methemoglobinemia Because of Dapsone: A Multiple Hit Hypothesis. Am J Ther. Jun 3 2011;[Medline].
Bauters T, Mondelaers V, Robays H, De Wilde H, Benoit Y, De Moerloose B. Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemia. Int J Clin Pharm. Feb 2011;33(1):58-60. [Medline].
Odièvre MH, Danékova N, Mesples B, Chemouny M, Couque N, Parez N, et al. Unsuspected glucose-6-phosphate dehydrogenase deficiency presenting as symptomatic methemoglobinemia with severe hemolysis after fava bean ingestion in a 6-year-old boy. Int J Hematol. May 2011;93(5):664-6. [Medline].
Bergamaschi MM, Alcantara GK, Valério DA, Queiroz RH. Curcumin could prevent methemoglobinemia induced by dapsone in rats. Food Chem Toxicol. Jul 2011;49(7):1638-41. [Medline].
US Food and Drug Administration. FDA Drug Safety Communication: Serious CNS reactions possible when methylene blue is given to patients taking certain psychiatric medications. Available at http://www.fda.gov/Drugs/DrugSafety/ucm263190.htm. Accessed July 27, 2011.
Carstairs SD, Tanen DA. Case studies in pediatric toxicology. Pediatr Ann. Dec 2005;34(12):973-8, 981. [Medline].
Dahshan A, Donovan GK. Severe methemoglobinemia complicating topical benzocaine use during endoscopy in a toddler: a case report and review of the literature. Pediatrics. Apr 2006;117(4):e806-9.
Geller RJ, Barthold C, Saiers JA, Hall AH. Pediatric cyanide poisoning: causes, manifestations, management, and unmet needs. Pediatrics. Nov 2006;118(5):2146-58. [Medline].
Hjelt K, Lund JT, Scherling B, et al. Methaemoglobinaemia among neonates in a neonatal intensive care unit. Acta Paediatr. Apr 1995;84(4):365-70. [Medline].
Jacka MJ, Kruger M, Glick N. Methemoglobinemia after transesophageal echocardiography: a life-threatening complication. J Clin Anesth. 2006;18(1):52-54. [Medline]. [Full Text].
Jaffe ER. Methemoglobin pathophysiology. Prog Clin Biol Res. 1981;51:133-51. [Medline].
Lebby T, Roco JJ, Arcinue EL. Infantile methemoglobinemia associated with acute diarrheal illness. Am J Emerg Med. Sep 1993;11(5):471-2. [Medline].
Lindenmann J, Matzi V, Kaufmann P, et al. Hyperbaric oxygenation in the treatment of life-threatening isobutyl nitrite-induced methemoglobinemia--a case report. Inhal Toxicol. Dec 2006;18(13):1047-9. [Medline].
Mansouri A, Lurie AA. Concise review: methemoglobinemia. Am J Hematol. Jan 1993;42(1):7-12. [Medline].
McMullen SE, Casanova JA, Gross LK, Schenck FJ. Ion chromatographic determination of nitrate and nitrite in vegetable and fruit baby foods. J AOAC Int. Nov-Dec 2005;88(6):1793-6. [Medline].

